ELAC2 and benign prostatic hyperplasia: Rökman et al (2001) genotyped 107 HPC cases, 467 unselected PrCa cases and 223 benign prostatic hyperplasia (BPH) cases and 568 healthy male blood donors for the two HPC2 variants Leu217 and Thr541.